ALT Altimmune Inc

Altimmune Inc is a clinical stage immunotherapeutic biotechnology company. It has two vaccine delivery platforms, RespirVec and Densigen.

$11.26  +0.47 (4.36%)
As of 12/02/2022 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/06/2005
Outstanding shares:  49,159,056
Average volume:  1,181,229
Market cap:   $530,426,214
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BFY7DC4
Valuation   (See tab for details)
PE ratio:   -4.81
PB ratio:   2.03
PS ratio:   -662.12
Return on equity:   -2.52%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy